How to Prevent HPV and Cervical Cancer

Hands holding a teal ribbon

Human papillomavirus (HPV) is the name of a group of viruses that infect the skin. Sexually transmitted HPV is very common. It is estimated that most sexually active women and men will come into contact with it during their life. Fortunately, in most cases of cases HPV will be naturally eliminated.

There are some types of genital HPV that can lead to cervical cancer. But the majority of people with a cervix who experience an HPV infection will not develop cervical cancer. In most cases cervical cancer can be prevented through early detection and treatment of abnormal cell changes.

Abnormal cell changes on the cervix caused by HPV are typically detected through a Pap test. A Pap test checks for abnormal or precancerous changes in the cells on the cervix. If the Pap test results show these cell changes, this is usually called cervical dysplasia. Other common terms the healthcare provider may use include:

  • Abnormal cell changes
  • Precancerous cells changes
  • CIN (cervical intraepithelial neoplasia)
  • SIL (squamous intraepithelial lesions)

All of these terms mean similar things—it simply means that abnormalities were found. There are several types of HPV that can cause cervical abnormalities and an abnormal Pap test result. But this does not mean cervical cancer will develop. It means that a health care provider will want to closely monitor thecervix every so often—and possibly do treatment—to prevent further cell changes that could become cancerous over time if left unchecked.

Cervical cancer is a slow-growing condition that usually takes years to progress. This is why getting screened on a regular basis is important; screening can catch any potential problems before they progress.

When and how do I screen for cervical cancer?

Screening begins with a Pap test at age 21 (screening is not recommended before 21), done every three years. At age 30, there are three different options:

  • A Pap test alone every three years
  • Co-testing with a Pap and HPV test, every five years
  • An HPV test alone, every five years

Depending on the results of the Pap and/or HPV tests, a healthcare provider may recommend additional screening or procedures, so some people may be screened more often.

After age 65, people older than 65 who have had adequate prior screening and are not otherwise at high risk can stop screening. Cisgender women or transmasculine people who have had a hysterectomy (with removal of the cervix) also do not need to be screened, unless they have a have a history of a high-grade precancerous lesions.

How do I prepare for a Pap or HPV test?

  • Try to schedule the test on a day when you do not expect to be on your menstrual period. If your period begins unexpectedly and will be continuing on the day of your test, try to reschedule the appointment.
  • Avoid sexual intercourse 48 hours before the test.
  • Do not douche 48 hours before the test.
  • Do not use tampons, or vaginal creams, foams, films, or jellies (such as spermicides or medications inserted into the vagina) for 48 hours before the test

What about abnormal test results?

The term “abnormal Pap” is broad and not very specific. There are many different systems that healthcare providers use to classify a Pap test. Within each system, there are different degrees of severity or abnormalities. The various classification systems and degrees of severity include:

Descriptive System

Degrees of Severity:

  • Mild dysplasia
  • Moderate dysplasia
  • Severe dysplasia

CIN* System

Degrees of Severity:

  • CIN 1
  • CIN 2
  • CIN 3

*CIN stands for cervical intraepithelial neoplasia

Bethesda System (2001)

Degrees of Severity:

  • ASC-US (Atypical Squamous Cells of Undetermined Significance): Means the results look borderline between “normal” and “abnormal” – often not HPV-related
  • ASC-H (Atypical Squamous Cells-can not exclude HSIL): Borderline results, but may really include High-Grade lesions
  • Low-Grade SIL (LSIL): SIL stands for squamous intraepithelial lesion
  • High-Grade SIL (HSIL)

People with abnormal Pap test results are usually examined further for cervical problems. This may involve coming back for a colposcopy and biopsy, or coming back in a few months for another Pap test. If the Pap result is “ASC-US,” then a HPV-DNA test may be done in the lab to see whether HPV is causing this borderline “normal-abnormal” Pap result.

Are the Pap test, HPV test, and biopsy the same?

A Pap test, or Pap smear, is a screening to find abnormal cell changes on the cervix (cervical dysplasia) before they ever have a chance to turn into cancer. During a pelvic exam, a small brush or cotton tipped applicator will be used to take a swab of cervical cells. These cells are then usually put in a container with liquid, and sent to the laboratory for evaluation.

A biopsy is similar to a Pap test, but a larger cluster of cells is removed from the cervix to see if there are abnormal cell changes. It is a good way to confirm the earlier Pap test result and to rule out cancer. If a biopsy is done, it will be performed at the same time as the colposcopy.

An HPV test is different than a Pap test or biopsy. This test checks directly for the genetic material (DNA) of HPV within cells, and can detect the “high-risk” types connected with cervical cancer. The test is done in a laboratory, usually with the same cell sample taken during the Pap test.

How is cervical dysplasia treated?

Currently, there is no treatment to cure HPV. However, there are several treatment options available for treating the abnormal cells. Sometimes treatment may not even be necessary for mild cervical dysplasia. These cells can heal on their own and the healthcare provider will just want to monitor the cervix. HPV may then be in a latent (sleeping) state, but it is unknown if it totally gone or just not detectable.

The goal of any treatment will be to remove the abnormal cells. This may also end up removing most of the cells with the HPV in them. If the abnormal cells are treated, or if they have healed on their own, it may possibly help reduce the risk of transmission to a partner who may have never been exposed to the cell-changing types of HPV.

When choosing what treatment to use, the healthcare provider will consider many things:

  • location of the abnormal cells
  • size of the lesions on the cervix
  • degree or severity of the Pap test results
  • degree or severity of the colposcopy and biopsy results
  • HPV test results (if this test was needed)
  • age and pregnancy status
  • previous treatment history
  • patient and healthcare provider preferences

There are a variety of treatments for cervical dysplasia:

  • Cryotherapy (freezing the cells with liquid nitrogen)
  • LEEP (Loop Electrosurgical Exision Procedure)
  • Conization (also called cone biopsy)
  • Laser (not as widely used today due to high cost, lack of availability, and not all doctors are well-trained with using it. LEEP is more commonly used)
  • No treatment at all since even mild abnormal cell changes may resolve without treatment. The healthcare provider may just monitor the cervix by either doing a colposcopy, repeat Pap testing, or a test for HPV.

What about HPV and pregnancy?

If someone has an abnormal Pap test during pregnancy, even if it’s severely abnormal, many healthcare providers will not do treatment, primarily due to the concern that it may accidentally cause early labor. They will just monitor the cervix closely with a colposcope during the pregnancy.

Sometime (a few weeks) after delivery of the baby, the provider will look at the cervix again and do another Pap test or another biopsy. Many times after pregnancy, the cell changes will have spontaneously resolved, and no treatment will be necessary. The types of HPV that can cause cell changes on the cervix and genital skin have not been found to cause problems for babies.

Learn More About HPV and Cervical Cancer

An image of HPV

HPV-Related Cancer

According to the Centers for Disease Control and Prevention (CDC), about 36,500 HPV-associated cancers occur in the U.S each year.
HPV Awareness

Too Few People Understand the Link Between HPV and Cancer

A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.
HPV vaccines

Is One Shot of the HPV Vaccine Enough? New Study Shows Promising Results

Is one shot enough? A recent study adds to evidence that one dose of the HPV vaccine might be enough to provide protection against cervical cancer.
HPV vaccination saves lives

Even More Evidence for the Value of Early HPV Vaccination

An exciting new study in Scotland found no cases of invasive cervical cancer in young women who had gotten the HPV vaccine by the time they were 14.
A uterus

New Option for Cervical Cancer Screening — Self Collected Samples

The FDA recently approved HPV testing using self-collected samples. Experts hope allowing people to collect their own samples will increase screening rates.

What You Need to Know About the HPV Self-Collection Test

There’s a new way to screen for cervical cancer—no pelvic exam, stirrups, or speculum involved.

The HPV Vaccine Prevents Cancer

In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.
Cervical pre-cancer

New Study Shows a Dramatic Drop in Cervical Pre-Cancers

A study has found a dramatic drop in the rates of cervical pre-cancers in young adult women—evidence that the HPV vaccine is working.
A exam table for a gynecological exam

Cervical Cancer Screening Rates Haven’t Rebounded After the Pandemic 

The pandemic interrupted our regularly scheduled doctor’s visits and pushed off preventative care like Pap tests.
An image of HPV

Human Papillomavirus (HPV)

Human papillomavirus, or HPV, is very common. Some types of HPV can cause genital warts and other types can cause cancer, including cancer of the cervix, vulva, vagina, penis or anus, as well as cancer in the back of the throat.
A child sits on her mother's lap after getting vaccinated

One and Done? New Study Suggests that One Dose of HPV Vaccine May Be Enough  

The results of large-scale study of HPV suggest that one shot of the vaccine may be enough to protect young people from HPV and related issues like cervical cancer.
A woman holds a Teal Wand, a device for at-home cervical cancer screening

FDA Approves At-Home Collection Device for Cervical Cancer Screening 

The FDA just approved the Teal Wand, a self-collection device for HPV testing that does not require a speculum exam or even a trip to the doctor’s office. People can collect their own sample at home and send it to a lab for analysis.
A stethoscope and a teal ribbon

ACS Releases New Cervical Cancer Screening Guidelines

The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.
Australia

Australia is Closer to Ending Cervical Cancer

Australia has been a leader in cervical cancer prevention for decades and is now close to eliminating the disease.
An adolescent gives a thumbs up after getting an HPV vaccine

Is One Shot of the HPV Vaccine Enough?

Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.
HPV screening with self collection endorsed by two organizations

HPV Screening with Self Collection Endorsed by Three Organizations

Three organizations—ACS, ACOG, and HRSA—have each recently endorsed new guidelines for cervical cancer screening. All of them discuss screening with self collected samples.
A person holds a teal ribbon in their hands

Coping with Cervical Cancer

Listen as cervical cancer survivors discuss diagnosis, treatment, and survivorship, and offer advice on coping with cervical cancer.
Not today, cancer. No deaths from cervical cancer

A Breakthrough—No Deaths from Cervical Cancer in Young Women in England

For the first time ever, there were no deaths from cervical cancer among young women ages 20-24 in England over a five-year period. This is great news and adds to evidence that widespread HPV vaccination saves lives.